{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/02/3304986/0/en/Vera-Therapeutics-Announces-Alignment-with-U-S-FDA-on-Earlier-ORIGIN-Phase-3-Analysis-to-Support-Potential-Full-Approval-for-Atacicept-in-Adults-with-IgA-Nephropathy.html", "message": "News view counter 773000 successfully enlarged"}